ARTICLE
This course will describe recent changes in the epidemiology of opioid use disorder, including the current epidemic of fentanyl, carfentanil, and other fentanyl analogs. The course will review: 1) recent regulatory changes and their effect on clinical practice and collaborative care models, 2) the results of research studies comparing buprenorphine and extended-release naltrexone, 3) the impact of new medication formulations, including injectable buprenorphine, 4) evolving standards of care for medication-assisted treatment including models for the management of opioid overdose and the efforts to reduce or eliminate barriers to admission to long-term medication treatment, and 5) plans to expand access to evidence-based treatment within the justice system. Click here to access the Course of the Month and sign up for updates about this free member benefit.